E-Mail
IMAGE: Tom Mikkelsen, M.D., principal investigator for GBM AGILE at Henry Ford Cancer Institute, and medical director of the Precision Medicine Program and Clinical Trials Office at Henry Ford Health System.. view more
Credit: Henry Ford Health System
DETROIT (Feb. 3, 2021) - Henry Ford Cancer Institute is the first site in the world to activate two new treatments for glioblastoma (GBM), the deadliest form of brain cancer, as part of a patient-centered adaptive platform trial known as GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment). Led by Global Coalition for Adaptive Research (GCAR), GBM AGILE tests multiple therapies for patients with newly-diagnosed and recurrent GBM.
Henry Ford Cancer Institute Set to Begin Patient Care at Brigitte Harris Cancer Pavilion
The new 187,000-square-foot facility offers the most advanced cancer treatment options available, convenient access to clinical trials
News provided by
Share this article
Share this article
DETROIT, Jan. 19, 2021 /PRNewswire/ The Henry Ford Cancer Institute at Henry Ford Health System will open the doors of the new Brigitte Harris Cancer Pavilion on Jan. 20, 2021. Connected to Henry Ford Hospital by the Nancy Vlasic Skywalk over West Grand Boulevard, the new cancer pavilion is a global destination for seamless and integrated cancer care, bringing together the newest and most innovative treatment options including specialty clinics for 14 different types of cancer, precision medicine, clinical trials and supportive services.